… This study sought to provide post–cardiac transplant survival … mechanical circulatory support
and cardiac transplantation. … outcomes of patients with ACM who receive heart transplant …

… programs, driven by the anchoring bias of recent anecdotal experience and outcomes. …
characteristics and outcomes of patients who receive transplants for adriamycin-associated …

… registries for LVAD or heart transplant. We hypothesized that survival would be similar …
for patients with CCMP compared to ischemic cardiomyopathies (ICMP) and non-ischemic …

… cardiomyopathy underwent heart transplantation. … survival rates for Adriamycin-associated
cardiomyopathy were better than all other cardiomyopathies (for all other cardiomyopathies: …

… cardiomyopathy (AIC) may progress to end-stage heart failure requiring mechanical circulatory
support or orthotopic heart transplantation … cardiac interventions, and clinical outcomes in …

… and heart transplantation. Epidemiology of advanced heart failure in cancer survivors …
Perhaps the most important finding, aside from comparable post-transplant survival rates, …

… Orthotopic heart transplantation (OHT) has proven to be a useful therapy for patients with
heart failure (HF) secondary to adriamycin cardiotoxicity [1]. Little electrocardiographic data are …

… cardiomyopathy (CCMP… outcomes after heart transplant in those with and without a history
of cancer. Conversely, data regarding heart transplant in CCMP have shown mixed outcomes …

… (DOX) has significantly increased survival rates of pediatric and adult cancer … to cardiac
dysfunction and eventually congestive heart failure, resulting in the need for heart transplant or …

… ICD therapies, total mortality, heart transplantation, and left ventricular ejection fraction. … on
survival outcomes and thus allows for a better comparison by cardiomyopathy type. Indeed, in …